Stay updated with breaking news from Validive Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Camsirubicin Phase 1b Trial Currently at 5th Dose-Level , Generating Encouraging ResultsMNPR-101 Radiopharma Program Advancing Toward First-in-Human Studies WILMETTE, Ill., Aug. 10, 2023 --... -Today at 07:03 am- MarketScreener
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 whi...
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21...
WILMETTE, Ill., March 27, 2023 -- Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the... | March 27, 2023
Interim Analysis Planned for Q1 2023WILMETTE, Ill., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary